Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

• Published in: Neurobiology of aging 2006-04, Vol.27 (4), p.530-545
• Main Authors: McNaught, Kevin St. P., Olanow, C. Warren
• Format: Article
• Language: English
• Subjects: Animals; Humans; Lewy Bodies - metabolism; Lewy body; Models, Biological; Nerve Tissue Proteins - genetics; Nerve Tissue Proteins - metabolism; Parkin and ubiquitin–proteasome system; Parkinson Disease - classification; Parkinson Disease - genetics; Parkinson Disease - metabolism; Parkinson's disease; Proteasome Endopeptidase Complex - metabolism; Protein aggregation; Ubiquitin - metabolism; α-Synuclein
• ISSN: 0197-4580; 1558-1497
• DOI: 10.1016/j.neurobiolaging.2005.08.012

Parkinson's disease (PD) is a slowly progressive, age-related, neurodegenerative disorder. The cause and mechanism of neuronal death have been elusive. However, recent genetic, postmortem and experimental evidence show that protein accumulation and aggregation are prominent occurrences in both sporadic and familial PD. The relevance of these events to other cellular and biochemical changes, and to the neurodegenerative process, is being unraveled. It is increasingly evident that one or a combination of defects, including mutations, oxidative stress, mitochondrial impairment and dysfunction of the ubiquitin–proteasome system, lead to an excess production and aggregation of abnormal proteins in PD. In this respect, altered protein handling appears to be a central factor in the pathogenic process occurring in the various hereditary and sporadic forms of PD. This suggests that manipulation of proteolytic systems is a rational approach in the development of neuroprotective therapies that could modify the pathological course of PD.